Integrated Proteins Ltd Hits All-Time High of Rs 145 as Momentum Builds Across Timeframes

Price Action and Recent Performance

On the day it hit this record level, Integrated Proteins Ltd gained 1.61%, slightly outpacing the Sensex’s 1.55% rise. However, it underperformed its sector, Solvent Extraction, which advanced 4.62%. The stock has been on a two-day winning streak, accumulating a 3.61% gain in that period. Notably, it opened at Rs 145 and maintained that price throughout the session, indicating strong demand at this level. The stock currently trades above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — underscoring a robust technical setup. Does this alignment across multiple moving averages signal sustained momentum for the stock?

Exceptional Long-Term Returns

The stock’s performance over the past several years is eye-catching. It has delivered a staggering 6675.70% return over ten years, vastly outpacing the Sensex’s 186.99% gain in the same period. Year-to-date, the stock has surged 321.51%, while the Sensex declined 10%. Even over shorter intervals, such as three months, it has soared 188.10% compared to the Sensex’s modest 2.87%. This extraordinary appreciation reflects a combination of company-specific factors and sector tailwinds. However, such rapid gains often raise questions about valuation sustainability and whether the stock can maintain this pace.

Valuation Metrics Highlight Elevated Multiples

At the current price of Rs 145, Integrated Proteins Ltd trades at a price-to-earnings (P/E) ratio of 545 times trailing twelve months earnings, a figure that is exceptionally high relative to typical industry standards. The price-to-book value stands at 13.01x, while enterprise value to EBITDA and EBIT both hover around 267x. The EV to sales multiple is 27x, and EV to capital employed is 13x. These multiples suggest that the market is pricing in significant growth expectations or other qualitative factors, but they also imply stretched valuations that may warrant caution. At a P/E of 545, is Integrated Proteins Ltd still worth holding — or is it time to reassess?

Technical Indicators Show Mixed but Predominantly Bullish Signals

The overall technical trend for Integrated Proteins Ltd is bullish, with the trend having shifted from sideways to positive on 27 Mar 2026 at a price of Rs 71.33. Weekly and monthly MACD indicators are bullish, as are Bollinger Bands and the KST oscillator. Dow Theory also supports the upward trend. However, the weekly RSI is bearish, indicating some short-term overbought conditions or momentum fatigue. Delivery volumes have increased sharply, with a one-day delivery change of 82.45% compared to the five-day average, suggesting heightened investor interest. How might the conflicting RSI signal affect the sustainability of the current rally?

Financial Trend Reflects a Mixed Picture

Recent quarterly financials show a flat short-term trend as of March 2026. The company reported its highest quarterly PAT at ₹0.23 crores, a positive sign for profitability. However, net sales over the latest six months declined sharply by 73.53% to ₹5.69 crores, which raises concerns about revenue momentum. This disconnect between profit growth and sales contraction could indicate margin improvements or one-off factors influencing earnings. Is the recent profit growth sustainable given the steep sales decline?

Quality Metrics Suggest Average Fundamentals with Some Weaknesses

The company’s quality assessment is rated as average. Over the past five years, sales have grown at a compound annual growth rate of 61.22%, which is impressive. However, EBIT growth over the same period was a modest 6.65%. Return on capital employed (ROCE) averages at -4.21%, and return on equity (ROE) is low at 2.06%, indicating limited capital efficiency. The company carries negligible debt, with an average debt to EBITDA ratio of 0.46 and net debt to equity near zero, reflecting a strong balance sheet. Management risk is below average, and institutional holdings are minimal. The absence of promoter share pledging is a positive governance indicator. How do these mixed quality metrics influence the risk profile of the stock?

Key Data at a Glance

Balancing Bull and Bear Cases

The rally in Integrated Proteins Ltd is supported by strong technical momentum, impressive long-term returns, and a clean balance sheet with negligible debt. Yet, the valuation multiples are stretched to levels that few companies sustain without significant earnings growth. The recent sales decline juxtaposed with a rise in profits adds complexity to the fundamental picture. Quality metrics reveal average operational efficiency and weak returns on capital, which may temper enthusiasm despite the price action. Should you buy, sell, or hold? With momentum and valuations pulling in opposite directions, no single data point tells the full story — see the complete multi-factor analysis of Integrated Proteins Ltd to find out.

Conclusion

Reaching an all-time high of Rs 145 marks a significant achievement for Integrated Proteins Ltd, reflecting a powerful rally that has outpaced the broader market and sector indices. The technical indicators largely support the current uptrend, but the elevated valuation multiples and mixed fundamental signals suggest that investors may want to approach with measured caution. The stock’s journey from Rs 20.71 to Rs 145 within a year is extraordinary, yet the sustainability of this momentum depends on whether earnings and sales trends can align more favourably in coming quarters.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →